This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2003 Remove Cannabis Remove Microdosing Remove Sleep
article thumbnail

Here’s What Neuroimaging Can Tell Us About the Psychedelic Experience

SpeedWeed

MAY 22, 2021

Due to it’s high temporal value, EEG shines at detecting epilepsy, sleep disorders, dementia and any other structural brain disease or disorder. This isn’t like the indica and sativa of cannabis (which actually doesn’t even exist ). There are a multitude of applications for electroencephalography. Daumann et al. Kaelen et al.

Research and Development 52
Research and Development Microdosing Wellness and Beauty Pets 52
article thumbnail

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

JUNE 4, 2021

David John Nutt is an English neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. a leading biotech company in the hemp and cannabis industries. Previously, David was co-founder & CPO at cannabis company Baker Technologies. Drug Science.

Research and Development 51
Research and Development Medicine Treatment Pharmaceutical 51
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 24,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024